April 19-20,2018Day one morning-Global Industry trends
Day one afternoon to Day two
Stream A -Drug Substance
Stream B --Formulation Design and development
Stream C-- Analytical Development and Support
Stream D-- Regulatory Planning and BE Studies Session
Beijing Scinovo Laboratories Ltd
In November 2016, Beijing Scinovo Laboratories Ltd was established, The registered capital was RMB20 million, the actual investment is nearly RMB 40 million. The newly establishedlab is more than 1100 m2, and the design and construction areadopted the International Standards .Our lab uses AB mass spectrometers(API4000, 4500, 5500) recommended by FDA as primary equipment for testing. Wealso use Watson LIMS software, which is the most popular internationallaboratory management system.
Beijing ScinovoLaboratories Ltd focuses on biological samples analysis, including the consistencyevaluation of generic drug/study of bioequivalence/Phase I clinical trial ofinnovative drug. We have established a strategic partnership witha large number of domestic pharmaceutical companies and clinical researchinstitutions.
We are strivingto establish an open testing platform , which is not only satisfiedwith domestic and international standards, but also provides Laboratory R& D and production services for global pharmaceutical, biotech andmedical devices fields from drug discovery to marketization process.